Sign up to save your podcasts
Or
Share ACCEL Lite: Selecting an Oral P2Y12 Inhibitor Post-MI: What’s the Best Choice?
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
ACCEL Lite: Selecting an Oral P2Y12 Inhibitor Post-MI: What’s the Best Choice?
In this interview, Francesco Franchi, MD and Spencer B. King III, MD, MACC, with Matt A. Cavender MD, MPH, FACC, discuss how to make the best choice when selecting an oral P2Y12 inhibitor post-MI.
View all episodes
By American College of Cardiology
3.7
5353 ratings
In this interview, Francesco Franchi, MD and Spencer B. King III, MD, MACC, with Matt A. Cavender MD, MPH, FACC, discuss how to make the best choice when selecting an oral P2Y12 inhibitor post-MI.
More shows like ACCEL Lite: Featured ACCEL Interviews on Exciting CV Research
View all
JAMA Editors' Summary
131 Listeners
NEJM This Week
323 Listeners
JACC Podcast
160 Listeners
This Week in Cardiology
863 Listeners
JAMA Clinical Reviews
496 Listeners
Mayo Clinic Talks
274 Listeners
The Curbsiders Internal Medicine Podcast
3,318 Listeners
JAMA Medical News
86 Listeners
Eagle's Eye View: Your Weekly CV Update From ACC.org
135 Listeners
Core IM | Internal Medicine Podcast
1,084 Listeners
ACC CardiaCast
39 Listeners
Annals On Call Podcast
186 Listeners
Harrison's PodClass: Internal Medicine Cases and Board Prep
351 Listeners
Cardionerds: A Cardiology Podcast
424 Listeners
Mayo Clinic Cardiovascular CME
34 Listeners